Dyne Therapeutics
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $128M
Investors
- 8
About Dyne Therapeutics
In May 2024, Dyne Therapeutics Inc.5 million shares at USD 31 per share on the NASDAQ under the ticker symbol "DYN". Dyne Therapeutics Inc.57 million shares of common stock. Dyne Therapeutics Inc. provides muscle-targeted therapies in the biopharmaceutical field. The company’s pipeline includes promising clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), with a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). In addition, the firm offers preclinical data from the FORCE platform in delivering enzyme replacement therapy to muscle and the central nervous system in Pompe disease.
Who invested in Dyne Therapeutics
8 investors across 3 rounds
See all investors in Dyne Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dyne Therapeutics
Who invested in Dyne Therapeutics?
Dyne Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dyne Therapeutics raised?
Dyne Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Dyne Therapeutics last raise money?
Dyne Therapeutics's most recent round on record is a Series B, in Aug 2020.
What does Dyne Therapeutics do?
In May 2024, Dyne Therapeutics Inc.
Where is Dyne Therapeutics headquartered?
Dyne Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Dyne Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dyne Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Dyne Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.